Rosetta Genomics (ROSG) stock surged on Friday after Cantor Fitzgerald initiated coverage on the stock with a 'speculative buy' rating.
These biotech stocks are within range of triggering breakout trades. Here's how to trade them now.
Rosseta Genomics (ROSG) shares are climbing after analysts at Cantor upgraded the stock to 'buy' from 'hold' today.
Rosetta Genomics (ROSG) shares are up double digits after the company announced that it received a patent for its cancer diagnostic assay.